North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Product Description
In-house Standards
AI Product Description
*The following content is generated by AI and is for reference only.
<h3>Overview</h3>
<p><strong>Clarithromycin</strong> (CAS 81103-11-9) is a semi-synthetic macrolide antibiotic derived from erythromycin via C-6 methylation. It features the molecular formula <strong>C38H75NO13</strong> and is produced through fermentation followed by chemical modification to enhance acid stability.</p>
<h3>Application</h3>
<ul>
<li>Treatment of respiratory tract infections including pneumonia and bronchitis.</li>
<li>Mitigation of skin and soft tissue bacterial infections.</li>
<li>Combination therapy for Helicobacter pylori eradication in peptic ulcers.</li>
<li>Management of atypical mycobacterial infections in immunocompromised patients.</li>
</ul>
<h3>Precautions</h3>
<p>Contraindicated with ergot alkaloids, cisapride, and pimozide due to QT prolongation risks. Store in cool, dry conditions below 25°C away from moisture. Use appropriate PPE during handling to prevent respiratory sensitization.</p>